Development action with informed and engaged societies

After nearly 28 years, The Communication Initiative (The CI) Global is entering a new chapter. 

Following a period of transition, the global website has been transferred to the University of the Witwatersrand (Wits) in South Africa, where it will be administered by the Social and Behaviour Change Communication Division. Wits' commitment to social change and justice makes it a trusted steward for The CI's legacy and future. 

On the transfer, co-founder Victoria Martin expressed her pleasure to see this work continue under Wits' leadership, knowing that co-founder Warren Feek (1953–2024) would have felt deep pride in The CI Global's Africa-led direction. 

As Wits, we honour the team and partners who sustained The CI for decades and look forward building from that strong base. This includes co-founders Warren Feek (1953-2024) and Victoria Martin as well as La Iniciativa de Comunicación (CILA), which continues independently at lainiciativadecomunicacion.com with links to The CI Global site. We are also eager to forge new partnerships and entertain new ideas as we consider how best to contribute to social and behaviour change in our rapidly evolving environment.

If you are joining the International Social and Behaviour Change Communication (SBCC) Summit in Panama, please join Wits and CILA on Monday, 22 June, to share your thoughts and suggestion for the relaunch of the Communication Initiative. We will be in Pacifica 5 from 12-1:25 for the Refuel, Reflect, and Renew Lunch Series: The Communication Initiative: celebrating a driving force for Communication for Social Change and the way forward. We will reflect on the legacy of Warren Feek and family in creating the Communication Initiative, consider the contributions of CI over the years and then turn our attention towards the future in this dynamic session. 

If you are unable to join us in Panama, we still want to hear from you. Please contribute your thoughts by following this link: https://redcap.link/CommunicationInitiative2026 or reaching out to ci_surveys@commint.com

You can also follow the QR Code:

 https://redcap.link/CommunicationInitiative2026

Time to read
2 minutes
Read so far

Medicines Transparency Alliance (MeTA) in Zambia

0 comments
The Medicines Transparency Alliance (MeTA) is an alliance of partners working at both national and international levels to improve access to medicines by increasing transparency and accountability in the healthcare marketplace. Launched in March 2009, the Zambia country programme is based on the premise that working together has the potential to improve governance, transparency, and accountability in the medicine supply chain and, ultimately, to improve people's health. In addition to Zambia, participating MeTA countries include: Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, and Uganda.
Communication Strategies

MeTA is based on the premise that bringing together various stakeholders - the private sector, civil society, the government, and other interest groups - in both face-to-face and virtual gathering spaces can spark action for supporting the development of viable, efficient medicines markets and supply systems.

Civil society organisations (CSOs) have been active in building the MeTA strategy in Zambia. Four Zambian CSO representatives took part in a skills-building seminar in Uganda in February 2008 designed to improve the capacity of the health sector to ensure that patients take appropriate, affordable, safe medicines when they are needed. A number of skills development sessions provided opportunities for participants to sharpen their abilities in research, communication and advocacy, and influencing and negotiating. They also explored how to monitor prices, improve collaboration and networking, make use of a rights approach to access to medicines, engage with the media, interpret data, develop policy briefs, and understand equity issues. A key feature of all the skills sessions was the emphasis on building on the experience of the participants and sharing that experience. The Zambia group met separately, which led to the resolution to brief the wider CSO community and meet other organisations participating in the MeTA process, to develop a baseline assessment of the situation in their country, and to organise an advocacy strategy.

Development Issues

Health, Rights.

Key Points

"Bribery in the health system results in higher drug prices", Goodwell Lungu of Transparency International Zambia said as MeTA Zambia was being formed. And, Lungu elaborated, lack of information for patients about services and medicines - about where and when they are provided, about who provides them, and the procedures to be followed - creates an environment in which corruption can flourish.

Recent health reforms in Zambia aim to "provide equity of access to cost-effective, quality health care as close to the family as possible." But, according to MeTA Zambia, there are 3 main challenges around access to health: proximity to services, costs, and human resources. In urban areas, 99% of households are within 5 kilometres of a health facility as compared to 50% in rural areas. Household expenditures on health also vary according to location; economically poorer rural households spend a higher proportion on health when costs in kind are included. Human resources are also strained due to medical staff leaving the country or moving from the public sector to the private sector, as well as the impact of HIV and AIDS.

MeTA Zambia explains that, in recent years, failures in the procurement and supply of medicines have been acknowledged, with essential drugs often out of stock. The connection between the different units and health care facilities and the related information system (health care facilities sending up usage data to forecast, placing orders before drugs get out of stock, etc.) did not work routinely, forcing emergency procurements when/if funds were available. This led to high prices being paid, further deteriorating the situation.

Partners

The UK Department for International Development (DFID) is providing initial funding. Other partners include governments, global and national civil society organisations, pharmaceutical and other business interests, the World Health Organization (WHO), and the World Bank.

Sources

MeTA website, accessed on March 20 2009.